[
    [
        {
            "time": "",
            "original_text": "普联软件、凯淳股份、山水比德创业板IPO与健帆生物可转债申请通过审核",
            "features": {
                "keywords": [
                    "普联软件",
                    "凯淳股份",
                    "山水比德",
                    "创业板IPO",
                    "健帆生物",
                    "可转债",
                    "审核通过"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "软件",
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "普联软件、凯淳股份、山水比德创业板IPO与健帆生物可转债申请通过审核",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "带量集采、医保目录谈判开启，大降价逃不掉，医药股还好吗？",
            "features": {
                "keywords": [
                    "带量集采",
                    "医保目录",
                    "谈判",
                    "大降价",
                    "医药股"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "带量集采、医保目录谈判开启，大降价逃不掉，医药股还好吗？",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]